Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
AXSOME THERAPEUTICS, INC. (AXSM), most recent 12 months reported: revenue $776.57M, net loss $191.64M, free cash flow -$71.96M. Latest balance sheet on file: liquid cash $319.85M, total debt $187.96M, net cash $131.89M. From SEC filings. More on AXSOME THERAPEUTICS, INC.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: CORCEPT THERAPEUTICS INC · SUPERNUS PHARMACEUTICALS, INC. · Collegium Pharmaceutical, Inc. · TG THERAPEUTICS, INC. · EMERGENT BIOSOLUTIONS INC. · Kiniksa Pharmaceuticals International, plc · PACIRA BIOSCIENCES, INC. · Amphastar Pharmaceuticals, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.